SOMERSET, NJ - Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, has announced that it is continuing with its extensive recruitment efforts despite the current COVID-19 pandemic.
Catalent has 17 sites across the U.S., including its 265,000 square-foot facility and headquarters, located on Schoolhouse Road, Somerset, which employs over 420 staff.
Reflecting growing market demand, the company is now looking to recruit over 60 employees in a range of roles, including manufacturing, product development, human resources, legal, supply chain, and more.
Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com